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Gene therapy aims to complement or, ideally, correct defective genes. The broad clinical application of this emerging
technology requires the development of safe high-capacity gene delivery vehicles that combine efficient transduction of
dividing as well as quiescent cells with sustained transgene expression. Here we present a new hybrid vector system that
unites favorable attributes of adenoassociated virus (AAV) and adenovirus (Ad) vectors in a single particle. This was achieved
by inclusion of Ad packaging elements in different sized recombinant AAV genomes. In the presence of AAV replicative
functions and a recombinant helper Ad, AAV/Ad hybrid particles were generated via encapsidation of AAV-dependent
replicative intermediates into Ad capsids. In stringent in vitro models based on transduction of proliferating cells we show
that AAV/Ad hybrid vectors are superior to Ad vectors in establishing prolonged transgene expression and can be used to
deliver DNA fragments of at least 27 kb. © 2001 Academic Press
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The development of vectors that enable efficient gene
delivery and stable transgene expression is regarded as
one of the main priorities in the gene therapy field (Verma
and Somia, 1997). Currently, the most efficient vector
system for in vivo transduction is based on adenovi-
ruses. These vectors can be grown to high titers in cell
lines expressing the essential genes that were deleted
from the adenovirus (Ad) genome. Furthermore, Ad cap-
sid-mediated DNA import into the nucleus does not re-
quire cell division. Unfortunately, transgene expression is
generally transient as a result of the episomal nature of
the delivered DNA and due to the toxic effects and
immune responses induced by de novo synthesized viral
proteins in transduced cells (Yang et al., 1996). Recently,
a new class of Ad vectors has been developed in which
most or all viral genes are deleted (for a review see Hitt
et al., 1999). The minimal Ad sequences retained in these
so-called “gutless” vectors are the origins of replication
and the packaging elements (Schmid and Hearing, 1997).
Production of “gutless” vectors requires the presence of
a recombinant helper Ad to provide in trans all necessary
functions involved in genome replication and packaging.
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236As a consequence of the removal of most viral se-
quences, these vectors can accommodate large frag-
ments of foreign DNA (up to 37 kb) and are less immu-
nogenic than their earlier counterparts (Schiedner et al.,
1998; Sandig et al., 2000). However, this approach does
not address the episomal status of the transferred DNA
which will result in loss of the therapeutic gene upon
target cell division.
In contrast, long-term transduction of dividing cell pop-
ulations has been accomplished by using adenoassoci-
ated virus (AAV) vectors. This can be explained by the
absence of viral genes from these vectors and by their
chromosomal integration ability. AAV is a parvovirus with
a linear single-stranded (ss) DNA genome of 4.7 kb that
requires a helper virus (e.g., Ad) for a productive infec-
tion. The viral genome consists of two genes, rep (repli-
cation) and cap (capsid), flanked by inverted terminal
repeats (ITRs). The ITRs contain all cis-acting sequences
involved in viral DNA replication, genome packaging,
and chromosomal integration. Typically, AAV vectors are
generated by transfecting producer cells with a plasmid
containing a recombinant AAV (rAAV) genome composed
of foreign DNA flanked by AAV ITRs and a construct
expressing in trans the viral rep and cap genes. In the
presence of Ad helper functions the rAAV genome is
rescued from the plasmid backbone, replicated, and
packaged into AAV capsids (for a review see Samulski et
al., 1999). An inherent disadvantage of AAV vectors is
their small cloning capacity (4.7 kb), rendering the deliv-
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237HIGH-CAPACITY AAV/Ad HYBRID VECTORery of large transcription units in a single particle impos-
sible (Dong et al., 1996). Moreover, the transduction ef-
ficiency is limited by their relatively slow nuclear import
(Bartlett et al., 2000; Hansen et al., 2000) and by the
inefficient conversion of the incoming genomes from
ssDNA molecules into transcriptionally competent dou-
ble-stranded (ds) DNA templates (Ferrari et al., 1996;
Fisher et al., 1996).
Here we present an AAV/Ad hybrid vector that com-
bines the complementary properties of the aforemen-
tioned gene delivery vehicles by linking the AAV replica-
tion mechanism to the Ad packaging process. Our sys-
tem is based on enlarged rAAV genomes provided with
Ad packaging elements. These AAV/Ad chimeric ge-
nomes were rescued, replicated, and packaged into Ad
capsids in the presence of AAV rep gene products and
n early region 1 (E1)-deleted Ad vector. The latter vector
rovided in trans both AAV helper activities and Ad struc-
ural proteins. This new AAV/Ad hybrid gene transfer
ystem overcomes the limited packaging capacity of AAV
articles and exploits the efficient Ad capsid-mediated
uclear gene delivery. Furthermore, AAV/Ad hybrid vec-
or transduction leads to prolonged reporter gene ex-
ression compared to transduction by an E1-deleted Ad
ector control.
RESULTS AND DISCUSSION
roduction of AAV/Ad hybrid vectors
AAV genomes are packaged in viral capsids as linear
sDNA molecules of approximately 4.7 kb in length
Berns and Giraud, 1996). Efficient Ad encapsidation, on
he other hand, is dependent on linear dsDNA molecules
ore than five times larger (Parks and Graham, 1997).
owever, AAV DNA replication is characterized by for-
ation of ds replicative intermediates and concatemer-
zation (Berns and Giraud, 1996). These phenomena
rompted us to investigate whether one could generate
AV/Ad hybrid particles by encapsidation of AAV-depen-
ent replicative intermediates in Ad capsids via Ad pack-
ging elements provided in cis. To this end, two AAV/Ad
huttle constructs were initially made (Fig. 1A). In con-
truct pAAV/AdC.5, the left AAV ITR flanks the human Ad
ype 5 (Ad5) packaging elements (Schmid and Hearing,
997), whereas construct pAAV/AdTRC.5 also contains
he contiguous left Ad5 inverted terminal repeat (AdTR).
n both instances, an Escherichia coli (E. coli) b-galac-
osidase (b-gal) gene (lacZ) under transcriptional control
of the cytomegalovirus immediate-early (IE-CMV) pro-
moter and the simian virus 40 polyadenylation (SV40 pA)
signal is located downstream of the Ad sequences. In
addition, we made a conventional rAAV shuttle construct
with the same lacZ reporter gene cassette (pAAV.5; Fig.
1A). To evaluate whether efficient AAV-mediated rescue
and replication of AAV/Ad chimeric genomes would be
possible, pAAV.5, pAAV/AdC.5, and pAAV/AdTRC.5 were
c
itransfected into E1-complementing PER.C6 cells alone
or together with an AAV rep expression plasmid
pP5.REP). Early Ad gene products that support AAV
eplication and late Ad proteins required for capsid as-
embly were both provided in trans by an E1-deleted Ad
ector (Ad.DE1.MLP.luc). Southern blot analyses of extra-
hromosomal DNA extracted from these cells at 48 h
osttransfection showed that accumulation of de novo
ynthesized DNA from all three constructs is dependent
n both AAV rep expression and Ad vector infection (Fig.
A, lanes 1, 3, and 5). In the absence of either one of
hese factors the characteristic AAV ds replicative forms,
.e., duplex monomers (DMs), duplex dimers (DDs), and
igh-molecular-weight (HMW) concatemers, were not
etected (Fig. 2A, lanes 2, 4, and 6–9). Furthermore,
pproximately the same replication levels were ob-
erved irrespective of the presence (pAAV/AdC.5 and
AAV/AdTRC.5) or the absence (pAAV.5) of Ad cis-acting
lements. We therefore concluded that AAV/Ad chimeric
enomes are efficiently rescued and replicated by the
AV replication machinery.
Next, we investigated whether these genomes could
e packaged in Ad capsids. Thus, the experiment de-
cribed above was repeated except that the incubation
eriod was extended until a complete cytopathic effect
as observed. The cell cultures were harvested and
FIG. 1. Schematic representation of AAV ITR-containing shuttle con-
structs. (A) The structure of pAAV/AdC.5 and pAAV/AdTRC.5 compared
to that of a standard rAAV construct pAAV.5. A I3 A VII corresponds to
the A-repeat elements that constitute the Ad5 packaging signal (AdC);
AdTR, Ad5 left ITR; numbers above gray boxes correspond to Ad5
genome nucleotide positions; black boxes, AAV ITRs. The transgene
expression cassette, ampicillin resistance gene (ampR), and bacterial
rigin of replication (ori) are also indicated. (B) The structure of the
nlarged AAV/Ad chimeric shuttle constructs pAAV/AdTRC.7 and
AAV/AdTRC.14. pAAV/AdTRC.14 differs from pAAV/AdTRC.7 in that it
ontains a human dystrophin intron 44 DNA fragment between the neoR
and lacZ expression cassettes. AdTRC, Ad5 left ITR and packaging
signal. For an explanation of the other symbols see above.leared lysates were used to infect HeLa and HepG2
ndicator cells. One day later, b-gal histochemistry was
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238 GONC¸ALVES ET AL.performed and gene transfer efficiencies were deter-
mined in terms of lacZ-forming units (LFU) by counting
blue nuclei. With the exception of cleared lysates derived
from cells transfected with pAAV.5 and pP5.REP all sam-
ples showed a direct correlation between AAV-mediated
replication and efficient transfer of reporter gene activity
(Fig. 2B). Based on these results we concluded that the
absence of Ad packaging elements from pAAV.5 uncou-
ples the AAV-mediated replication from the Ad encapsi-
dation process. Importantly, control samples from unin-
fected cells failed to transfer any reporter gene activity
even when they had been transfected with pP5.REP and
pAAV/AdC.5 or pP5.REP and pAAV/AdTRC.5. Finally it is
of note that, in both indicator cell lines, cleared lysates
from cells transfected with pAAV/AdTRC.5 and pP5.REP
and infected with Ad.DE1.MLP.luc helper vector yielded a
reproducibly higher number of LFU than when pAAV/
AdC.5 was used to provide AAV/Ad chimeric genomes
(Fig. 2B). This observation suggests an involvement of
AdTR sequences in the Ad encapsidation process, as
has been recently proposed (Schmid and Hearing, 1998).
Both sets of experiments showed that the generation of
AAV-dependent replicative intermediates containing Ad
packaging elements correlated with the lacZ transducing
activity of the AAV/Ad hybrid vector preparations. This
finding vindicated our approach of combining the repli-
cation and packaging processes from two unrelated vi-
ruses in order to generate a new hybrid vector.
Next, we wanted to test whether one could exploit the
packaging capacity of Ad capsids to transduce AAV/Ad
chimeric genomes containing large fragments of foreign
DNA. For this purpose, a second expression cassette
consisting of the neoR gene flanked by the herpes sim-
lex virus (HSV) thymidine kinase gene promoter and
olyadenylation signal was cloned into pAAV/AdTRC.5,
iving rise to the pAAV/AdTRC.7 shuttle construct (Fig.
B). A further increase in AAV/Ad chimeric genome size
as accomplished by inserting a fragment from intron 44
f the human dystrophin gene into pAAV/AdTRC.7 (Fig.
B). The resulting shuttle construct pAAV/AdTRC.14 com-
rises an AAV/Ad chimeric genome of 13.8 kb (Fig. 1B).
AV-mediated replication of these enlarged genomes
as tested by transfecting pAAV/AdTRC.5, pAAV/
dTRC.7, or pAAV/AdTRC.14 into PER.C6 cells together
ith pP5.REP. The tranfected cells were subsequently
nfected with the Ad.DE1.MLP.luc helper vector and ex-
rachromosomal DNA was extracted at 48 h posttrans-
ection. Southern blot analyses of de novo synthesized
NA showed a decrease in the accumulation of AAV-
ependent replicative intermediates with the increase in
AV/Ad chimeric genome size (Fig. 3). These results
ndicated that the AAV and Ad replication machineries
ere competing for one or more trans-acting factors that
ecame limiting with the enlargement of the AAV/AdFIG. 2. Requirements for AAV/Ad hybrid vector production. (A)
Replication analyses of AAV ITR-containing constructs. AAV ITR-
containing constructs pAAV.5 (lanes 1 and 2), pAAV/AdC.5 (lanes 3
and 4), and pAAV/AdTRC.5 (lanes 5–8) were transfected into PER.C6
cells alone or together with the AAV rep expression plasmid
pP5.REP. With the exception of samples corresponding to lanes 7
and 8, transfected cells were subsequently infected with
Ad.DE1.MLP.luc at an m.o.i. of 5 IU/cell. Lane 9, PER.C6 cells in-
fected with Ad.DE1.MLP.luc. At 48 h posttransfection extrachromo-
somal DNA was extracted, DpnI-digested, and resolved in a 0.7%
agarose gel. DpnI requires its overlapping DNA adenine methylase
(DAM) site to be methylated for digestion. Since eukaryotic cells
lack this activity, DNA replicated in these cells is DpnI-resistant,
whereas transfected prokaryotic DNA retains its DAM methylation
pattern and is DpnI-sensitive. After Southern blotting the DNA was
incubated with a 32P-labeled lacZ fragment and the filter was sub-
ected to autoradiography. The characteristic DpnI-resistant AAV-
ependent replicative forms, DMs, DDs, and HMW concatemers are
ndicated. (B) Encapsidation analyses of AAV ITR-containing
onstructs. pAAV.5, pAAV/AdC.5, and pAAV/AdTRC.5 were trans-
ected into PER.C6 cells alone or together with the AAV rep expres-
ion construct pP5.REP. Transfected cells were infected with
d.DE1.MLP.luc at an m.o.i. of 5 IU/cell at 3 h posttransfection (n 5
). Three to four days later the cells were harvested and lysed by
hree cycles of freezing and thawing. Cellular debris was removed
y centrifugation and the recovered supernatants were filtrated
nd used to infect HeLa or HepG2 indicator cells. Twenty-four hours
ostinfection the number of transduced cells was determined
y b-gal histochemistry. Cleared lysates from transfected cells
that were not infected with Ad.DE1.MLP.luc failed to transfer
himeric genomes.
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239HIGH-CAPACITY AAV/Ad HYBRID VECTORstrand displacement mechanism (Berns and Giraud,
1996; Van der Vliet, 1995). Moreover, Ad DNA elongation
is dependent on the Ad DNA-binding protein (DBP) en-
coded by the E2a gene. This protein binds cooperatively
o ssDNA in a non-sequence-specific manner. Through
ultimerization via its C-terminal arm, DBP forms a rigid
rotein chain at the displaced DNA strand protecting it
rom nuclease digestion and inhibiting intramolecular
enaturation (Dekker et al., 1997). In addition, DBP is one
of the Ad proteins that provide AAV helper activity. Thus
we investigated if limiting amounts of DBP could explain
the decreased replication efficiency of the enlarged
AAV/Ad chimeric genomes. The shuttle constructs pAAV/
AdTRC.5 and pAAV/AdTRC.14 were individually trans-
fected into PER.C6 cells with pP5.REP alone or with
pP5.REP plus the Ad E2a expression plasmid pCMV.E2a.
The transfected cells were then infected with the E1-
deleted Ad helper vector. Southern blot analyses of AAV-
dependent replicative intermediates extracted from
these cells showed that DBP levels were indeed limiting
for the efficient replication of enlarged AAV/Ad chimeric
genomes (Fig. 4, compare lanes 2 and 4). Based on this
finding we postulate that DBP is directly involved in AAV
DNA replication by binding to and stabilizing the dis-
FIG. 3. Replication analyses of enlarged AAV/Ad chimeric genomes.
pAAV/AdTRC.5, pAAV/AdTRC.7, and pAAV/AdTRC.14 were individually
transfected into PER.C6 cells together with the AAV rep expression
plasmid pP5.REP. Transfected cells were infected with Ad.DE1.MLP.luc
at an m.o.i. of 5 IU/cell. Two days later extrachromosomal DNA was
extracted, DpnI-digested, and resolved in a high-strength 0.4% agarose
gel. After Southern blotting the DNA was incubated with a 32P-labeled
lacZ fragment and the filter was subjected to autoradiography. The
sizes and positions of AAV-dependent replicative forms are indicated.placed ssDNA templates. Accordingly, with the increase
in length of the template DNA, more DBP molecules
w
dwould have to be recruited to protect the displaced DNA
strand and to maintain it in a conformation suitable for
DNA elongation. A direct involvement of DBP in AAV DNA
replication is further supported by in vitro studies per-
formed by Ward and co-workers (1998) showing that in
extracts of Ad-infected cell, DBP was the component
supporting processive AAV replication.
After having set the requirements for efficient AAV-
mediated replication of the 13.8-kb AAV/Ad chimeric ge-
nomes, we investigated their packaging in Ad capsids.
Thus, PER.C6 cells were transfected with constructs
pAAV/AdTRC.14, pP5.REP, and pCMV.E2a followed by
infection with Ad.DE1.MLP.luc. Cleared lysates derived
from these cells were used to infect indicator HeLa cells
reproducibly yielding vector titers of 3.1 3 104 LFU/ml.
hese titers were approximately fourfold higher than
hose obtained with the pAAV/AdTRC.5 shuttle construct,
ndicating that the 13.8-kb AAV/Ad chimeric genomes are
ore efficiently packaged than their 5.0-kb counterparts.
his may relate to the existence of a lower genome size
imit of approximately 27 kb for efficient Ad DNA pack-
ging (Parks and Graham, 1997) and to the generation of
Ds within this size range during AAV-mediated replica-
ion of the 13.8-kb AAV/Ad chimeric genome (Fig. 4,
ane 4).
FIG. 4. Effect of Ad E2a overexpression on the rescue and replication
of AAV/Ad chimeric genomes. pAAV/AdTRC.5 and pAAV/AdTRC.14
were individually transfected into PER.C6 cells with the AAV rep ex-
pression plasmid pP5.REP alone (lanes 1 and 2) or with pP5.REP plus
the Ad5 E2a expression plasmid pCMV.E2a (lanes 3 and 4). Transfected
cells were infected with Ad.DE1.MLP.luc at an m.o.i. of 5 IU/cell. Two
days later extrachromosomal DNA was extracted, DpnI-digested, and
resolved in a high-strength 0.4% agarose gel. After Southern blotting
the DNA was incubated with a 32P-labeled lacZ fragment and the filteras subjected to autoradiography. The sizes and positions of AAV-
ependent replicative forms are indicated.
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240 GONC¸ALVES ET AL.Properties of AAV/Ad hybrid vector particles
Our previous experiments showed that only AAV ITR-
containing shuttle constructs with Ad packaging ele-
ments yielded vector preparations with high lacZ transfer
activity. To demonstrate that AAV/Ad hybrid vectors are
AAV-replicative intermediates incorporated in Ad cap-
sids, an AAV/AdTRC.14 vector preparation was sub-
jected to different treatments. Incubation for 1 h at 56°C,
condition that is routinely used to inactivate Ad parti-
les, completely abrogated reporter gene delivery,
hereas it was not abolished by treatment with 1 mg/ml
f DNase I for 30 min at 37°C. Furthermore, incubation
ith 100 mg/ml of proteinase K for 1 h at 37°C dramati-
ally reduced lacZ gene transfer (Fig. 5A). Finally, addi-
ion of rat serum containing Ad5-specific antibodies to
he vector preparation effectively blocked reporter gene
elivery. Importantly, serum taken from the same animal
efore Ad5 immunization did not have any effect on lacZ
ransfer efficiency (Fig. 5B). These experiments con-
irmed that Ad capsids are the vehicles involved in
AV/Ad chimeric genome delivery.
rolonged transgene expression is achieved via AAV/
d hybrid vector transduction
In another set of experiments, the ability of the AAV/
dTRC.14 hybrid vector to mediate prolonged transgene
FIG. 5. Effect of different treatments on the reporter gene transfer
ability of AAV/AdTRC.14 hybrid vector preparations. (A) An AAV/
AdTRC.14 hybrid vector preparation was divided into aliquots that were
subjected to the indicated treatments and used to infect indicator HeLa
cells. After incubation for 1 h the inoculum was replaced by fresh
medium and b-gal histochemistry was performed at 24 h postinfection.
(B) An AAV/AdTRC.14 hybrid vector preparation was divided into ali-
quots that were incubated with an equal volume of DMEM, rat serum
obtained before Ad5 immunization, or rat serum collected after Ad5
immunization. Each rat serum was diluted 1:5 in DMEM before addition
to the vector stock. After a 30-min incubation period at 37°C the
samples were added to indicator HeLa cells. One hour later the
inoculum was replaced by fresh medium and b-gal histochemistry was
erformed at 24 h postinfection. Data represent averages from two
ndependent experiments.xpression in highly dividing cell populations and in the
bsence of selective pressure was investigated.Rat bronchial carcinoma L42 and human cervical
arcinoma HeLa cells were infected with 0.1 and 0.004
FU/cell, respectively, of AAV/AdTRC .14 or
d.DE1.CMV.lacZ. Ad.DE1.CMV.lacZ is an E1-deleted Ad
ector with the same transgene expression cassette as
AV/AdTRC.14. This vector was either added to the cells
irectly or after being spiked with the same amount of
d.DE1.MLP.luc present in the hybrid vector preparation.
ells were infected for 3 h and then washed to remove
ny free particles. Infected cells were cultured for vari-
us time periods and subsequently assayed for the ex-
ression of lacZ by b-gal histochemistry. Prior to b-gal
staining the cells were seeded at low densities and
allowed to reach confluence over a period of 6 to 7 days.
The detection of blue foci of b-gal-positive cells at late
ime points postinfection revealed that transduction of
oth cell lines by the AAV/Ad hybrid vector led to longev-
ty of transgene expression (Fig. 6). The clustered distri-
ution of these cells may be explained by the clonal
xpansion of parental cells that had been stably trans-
uced with AAV/Ad vector sequences. Significantly,
d.DE1.CMV.lacZ-infected HeLa and L42 cultures did not
FIG. 6. Transduction of target cells with the AAV/AdTRC.14 hybrid
vector leads to prolonged reporter gene expression. (A) HeLa and (B)
L42 cells were infected with equivalent LFU of either AAV/AdTRC.14
hybrid vector or Ad.DE1.CMV.lacZ E1-deleted vector and analyzed for
long-term lacZ expression by b-gal histochemistry. L42 cells were
analyzed at 43 days post infection, whereas HeLa cells were analyzed
at 21 days post infection. Two characteristic foci are shown. At the
same time points after infection Ad.DE1.CMV.lacZ-transduced cells
were b-gal negative.
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241HIGH-CAPACITY AAV/Ad HYBRID VECTORcontain, at the same time points postinfection, any b-gal-
positive cells.
Propagation of AAV/Ad hybrid vector
Replication of AAV/Ad chimeric genomes is dependent
on AAV replicative functions. Thus, propagation of
AAV/Ad hybrid vectors requires that the packaged DNA
molecules contain functional AAV ITRs. To test this hy-
pothesis we provided by plasmid transfection PER.C6
producer cells with AAV Rep proteins and, based on
observations reported in this paper, Ad DBP. A prepara-
tion containing Ad.DE1.MLP.luc helper virus and the in-
dicated amounts of AAV/AdTRC.14 hybrid vector (Table 1)
was subsequently added to the transfected cells. Ex-
tracts of these cells were assayed for the presence of
functional AAV/Ad vector particles. Data summarized in
Table 1 show that, in the presence of AAV rep and Ad E2a
expression, AAV/AdTRC.14 could be amplified, whereas
in the absence of AAV Rep proteins no amplification was
observed. The fact that AAV/Ad hybrid vector propaga-
tion is dependent on AAV rep expression demonstrates
that the delivered AAV ITRs remain functional origins of
replication enabling the hybrid vector DNA to be repli-
cated and packaged in permissive cells. Interestingly,
the lowest amount of input vector gave rise to the highest
amplification level, i.e., 103 hybrid vector LFU were am-
lified to an average number of 2.5 3 105 LFU. Con-
ersely, the highest amount of input vector was amplified
n average only 2.4-fold (Table 1). Overall, this experi-
ent provides the basis for the development of improved
omplementation methods based on the preferential en-
apsidation of AAV/Ad chimeric genomes over the helper
irus DNA.
In a parallel experiment, low-molecular-weight DNA
T
Effect of AAV rep Expression on the Amplification of the A
Experiment
pP5.REP 1 pCMV.E2a
Input AAV/Ad (3103) Total yield (3105) A
1 1 1.9
2 1 3.1
1 5 3.1
2 5 1.3
1 25 0.6
2 25 0.6
Note. —, Not done.
a PER.C6 cells were transfected either with expression plasmids pCM
ours posttransfection the cells were infected with a hybrid vector prep
AV/AdTRC.14 vector. After 72 h the cells were lysed and the amount of
histochemistry on HeLa indicator cells 24 h postinfection.
b Nuclear stained b-gal-positive HeLa cells were not observed at thxtracted from PER.C6 cells transfected with pP5.REP
nd pCMV.E2a and infected with an aliquot of the sameAV/AdTRC.14 vector preparation was subjected to
outhern blot analysis using a 32P-labeled lacZ fragment.
fter autoradiography, DpnI-resistant DNA forms of ap-
roximately 14 and 28 kb were detected. These DNA
orms were absent when the pP5.REP expression con-
truct was substituted by pUC19 carrier DNA (data not
hown). This result confirmed not only that the AAV ITRs
elivered by hybrid vector particles are indeed functional
ubstrates for AAV-mediated replication but also that the
acZ reporter gene is delivered as an integral part of a
3.8-kb AAV/Ad chimeric genome.
tructural analysis of AAV/AdTRC.14 hybrid vector
enomes
We postulated that the enhanced transgene delivery
chieved with AAV/AdTRC.14 vector preparations was
ue to the generation and efficient encapsidation of
inear AAV/Ad DD forms with a suitable size for efficient
d DNA packaging.
To test this hypothesis and, simultaneously, determine
he organization of AAV/AdTRC.14 genomes, a vector
atch concentrated by CsCl density gradient centrifuga-
ion and containing 106 LFU was subjected to sequential
Nase I digestion, proteinase K treatment, and DNA
xtraction. The extracted DNA was either digested with
hoI or XbaI or left undigested. After Southern blotting,
he transferred DNA was incubated with a 32P-labeled
lacZ expression cassette-specific probe. Control sam-
ples consisted of the parental 20.2-kb pAAV/AdTRC.14
shuttle construct digested with the same restriction en-
zymes. Digestion with XhoI linearizes the shuttle con-
struct, whereas XbaI cuts twice within the chimeric ge-
nome region, yielding fragments of 6.7 and 13.5 kb.
Figure 7A depicts the structure and expected restric-
RC.14 Hybrid Vector as Measured in lacZ-Forming Unitsa
pUC19 1 pCMV.E2a
ation Input AAV/Ad (3103) Total yield Amplification
3 1 ,100b ,0.1b3
3 — — —
3 5 500 0.13
3 — — —
3 25 2500 0.13
3 — — —
nd pP5.REP or with pCMV.E2a and control plasmid pUC19. Twenty-four
containing Ad.DE1.MLP.luc helper virus and the indicated amounts of
d hybrid vector in the clarified cellular extract was determined by b-gal
st dilution of the lysate.ABLE 1
AV/AdT
mplific
190
310
62
26
2.4
2.4
V.E2a a
aration
AAV/Ation fragment lengths of a rescued AAV/AdTRC.14 chi-
meric genome (DM) compared to the head-to-head (H-H)
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242 GONC¸ALVES ET AL.and tail-to-tail (T-T) dimeric intermediate forms predicted
by the AAV DNA replication model (Hong et al., 1992).
his model excludes the generation of replicative inter-
ediates with a head-to-tail (H-T) organization. The
mergence of H-H and T-T DDs and the absence of H-T
oncatemers has been experimentally proven by Hong et
al. (1994) and was confirmed in our system by restriction
enzyme and Southern blot analyses of AAV-dependent
replicative intermediates originated from the parental
pAAV/AdTRC.14 shuttle construct (data not shown).
Undigested DNA extracted from vector particles
yielded fragments with molecular weights of 13.8 and
27.6 kb (Fig. 7B). These sizes are consistent with the
encapsidation of full-length DMs and full-length DDs,
respectively. This result shows that hybrid vector parti-
cles packages both types of replicative intermediates
and, importantly, demonstrates that no aberrant vector
FIG. 7. (A) Structure of AAV-dependent replicative intermediates orig-
inating from the pAAV/AdTRC.14 shuttle construct. (B) Structural anal-
ysis of AAV/AdTRC.14 hybrid vector genomes by restriction mapping
and Southern blotting. A concentrated AAV/AdTRC.14 vector prepara-
tion containing 106 LFU was subjected to DNase I treatment, protein-
se K digestion, and DNA extraction. The packaged DNA was recov-
red by ethanol precipitation and was digested either with XhoI, or
baI, or left undigested (Und.).genome sizes are observed. Interestingly, there is an
increase in the prevalence of DDs over DMs in thepackaged DNA fraction compared to what is typically
observed in the extrachromosomal DNA fraction (com-
pare Fig. 7B with lane 4 of Fig. 4). This observation can
be explained by the preferential encapsidation of DDs
from a pool of available intermediates constituted in its
majority by DMs. Therefore, our data support the exis-
tence of the previously identified lower genome size limit
for efficient Ad DNA packaging (Parks and Graham, 1997)
and explain the increased transgene delivery of AAV/Ad
preparations generated with the enlarged pAAV/
AdTRC.14 shuttle construct. XhoI-digested DNA ex-
tracted from vector particles generated fragments with
molecular weights of 4.2, 9.6, and 19.2 kb, whereas
XbaI-digested material gave rise to species of 4.2 and 6.7
kb (Fig. 7B). The 4.2-, 9.6-, and 6.7-kb fragments can all
be contributed by DMs. However, the presence of the
19.2-kb fragments is only consistent with the packaging
of T-T dimers. Moreover, the absence of the 8.4-kb XhoI
and XbaI fragments expected from a H-H tandem implies
that these intermediates were not packaged at signifi-
cant levels. The latter observation might be explained by
the fact that this particular dimeric form has the Ad
packaging elements located far from either end of the
molecule. Previous studies demonstrated that for these
elements to be functional they must be located within a
limited distance from either extremity (Hearing et al.,
1987). To confirm that the encapsidated dimeric vector
molecules consist of T-T concatemers, the membrane
was rehybridized with a neoR-specific probe. This sec-
nd hybridization showed the presence of the previously
dentified 19.2-kb XhoI fragments. In addition, 5.8-kb XbaI
ragments indicative of T-T dimers were readily detected,
onfirming the structure of packaged dimers as being T-T
oncatemers (data not shown). We hence confirmed that
ybrid vector particles contain bona fide AAV-dependent
eplicative intermediates constituted of DMs and T-T
Ds.
Recently two hybrid gene transfer systems have been
eveloped that utilize Ad capsids to deliver rAAV ge-
omes (Recchia et al., 1999; Lieber et al., 1999). In both
nstances vector production is dependent either on Ad-
ediated replication alone (Recchia et al., 1999) or on
d-mediated replication together with AAV ITR-depen-
ent recombination (Lieber et al., 1999). Both strategies
reclude the delivery of free AAV ITRs into target cells.
urthermore, in the latter instance the hybrid vector ca-
acity is limited to what can be accommodated by early
eneration Ad vectors. The capacity issue has particular
mportance considering the increasingly accepted notion
hat genetic loci usually comprise extensive cis-regula-
ory elements necessary to maintain physiological-level
nd tissue-specific gene expression (e.g., b-globin gene
locus). For this reason, the development of gene delivery
vehicles with extended insert capacity is highly valuable.In summary, we demonstrated the ability to package
enlarged rAAV replicative intermediates in Ad capsids
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243HIGH-CAPACITY AAV/Ad HYBRID VECTORthrough the presence in cis of Ad encapsidation signals.
This strategy enables the generation of a new class of
hybrid vector that integrates efficient Ad capsid-medi-
ated transgene delivery, lack of viral genes, and a large
cloning capacity, the main features of the “gutless” Ad
vector approach, with prolonged transgene expression,
hallmark of rAAV vectors. The coupling of functional
elements from different viruses constitutes an emerging
paradigm in the development of improved gene transfer
vehicles. However, to our knowledge, this study repre-
sents the first demonstration that by combining the DNA
replication mechanism of one virus with the packaging
process of another dissimilar virus a new gene transfer
vector with combined attributes can be generated. This
scheme, demonstrated here between AAV and Ad com-
ponents, might be applicable in more general terms to
other viral gene delivery systems, increasing the plastic-
ity with which one can design new vectors.
MATERIALS AND METHODS
DNA constructions
Recombinant DNA techniques were performed using
established methods (Sambrook et al., 1989) or accord-
ing to the instructions supplied with specific reagents. All
AAV ITR-containing shuttle constructs have the gene for
a nuclear-targeted E. coli b-gal under the transcriptional
control of the IE-CMV promoter and the SV40 pA signal.
In construct pAAV.5 the two AAV ITRs flank exclusively
the expression cassette. In constructs pAAV/AdC.5 and
AAV/AdTRC.5, Ad5 nucleotides 104–454 and 1–454 are
nserted between the 59 ITR and the reporter gene cas-
ette, respectively (Fig. 1A). The 350-bp Ad5 fragment
as amplified by polymerase chain reaction (PCR) from
CMV.nls.lacZ (Fortunati et al., 1996) using an upstream
rimer (59-CCAAGCTTAGATCTTAGTGTGGCGGAAGTGT-
ATG-39) with HindIII and BglII recognition sites and a
ownstream primer (59-GGAAGCTTAGATCTGCGGCCG-
CTGACTATAATAATAAAACG-39) containing HindIII,
glII, and NotI restriction sites. The 454-bp Ad5 fragment
as amplified by PCR from the same plasmid using the
forementioned downstream primer but another up-
tream primer (59-CCAAGCTTAGATCTCATCATCAATA-
TATACCTTA-39) with HindIII and BglII recognition sites.
he PCR reactions were performed with 5 ng of template
NA and Pwo DNA polymerase (Boehringer Mannheim)
sing the reaction conditions recommended by the man-
facturer. PCR samples were heated for 2 min at 94°C
ollowed by 30 cycles of 94°C for 30 s, 55°C for 45 s, and
8°C for 2 min. The reactions were finished by incuba-
ion for 10 min at 68°C. The 350- and 454-bp PCR frag-
ents were then digested with HindIII and cloned into
indIII-digested pUC119 (Gibco BRL), generating plas-
ids pAdC and pAdTRC, respectively. Next, the lacZxpression cassette from plasmid pCMV.nls.lacZ (Fortu-
ati et al., 1996) was amplified by PCR using the Expand
s
fong Template PCR system (Boehringer Mannheim) ac-
ording to the manufacturer’s recommendations. The up-
tream primer (59- GCGTGGCCAGCGGCCGCATCGAT-
CTAGTCAGGTCGTTACATAACTTACGG-39) used for this
eaction contained NotI, ClaI, and SpeI recognition sites,
hile the downstream primer (59-CGCCTTGCGGCCGC-
ACGTGCGGTACCCCGCCACACTCGCAGGGTCTGCA-
9) had NotI, PmlI, and KpnI restriction sites. The PCR
eactions were carried out with 5 ng of template DNA.
he mixture was heated at 94°C for 2 min followed by 30
ycles of 94°C for 30 s, 55°C for 45 s, and 68°C for 4 min.
he reaction was completed by a 10-min incubation at
8°C. The resulting product was digested with NotI and
igated into NotI-digested pAdC and pAdTRC to yield the
lasmids pAdClacZ and pAdTRClacZ, respectively. The
equences of the cloned PCR fragments were confirmed
y restriction enzyme digestion and DNA sequence anal-
sis. Next, construct pWE20 was created by joining the
000- and 2357-bp PstI fragments of cosmid pWE15
Clontech) in a manner that restored the ampicillin gene.
ubsequently, construct pWE20 was digested with
indIII and ClaI, blunt-ended with the Klenow fragment of
. coli DNA polymerase I (DNA pol; Gibco BRL), and
igated to a phosphorylated NsiI linker (59-CGATG-
ATCG-39) to yield cosmid vector pWE25. The insertion
f the linker was confirmed by NsiI digestion and DNA
equence analysis. Construct pWE25 was linearized with
siI and ligated to the 1665-bp PstI fragment from plas-
id pTRBR (Ryan et al., 1996). The latter fragment consists
f AAV ITRs flanking the BglII J fragment from the Ad5
enome and a remnant of the SV40 pA signal. The
esulting construct was designated pWE25TR1. Finally,
he BglII fragments containing the Ad cis-acting ele-
ents and lacZ expression cassettes from pAdClacZ
nd pAdTRClacZ were ligated to the BglII-digested AAV
TR-containing vector backbone of pWE25TR1, giving
rise to the AAV/Ad shuttle constructs pAAV/AdC.5 and
pAAV/AdTRC.5, respectively. To generate the construct
pAAV.5, pAAV/AdTRC.5 was digested with BglII and the
fragment containing the cosmid backbone and the AAV
ITRs was blunted with DNA pol. The latter fragment was
ligated to the filled-in BglII–NotI fragment of pAAV/
AdTRC.5 encompassing the lacZ expression cassette. In
order to enlarge the cloned AAV/Ad chimeric genomes, a
neomycin resistance (neoR) gene flanked by the HSV
thymidine kinase gene promoter and polyadenylation
signal was isolated as an AvrII–SpeI fragment from plas-
mid 221 and ligated into the SpeI site upstream of the
IE-CMV promoter of pAAV/AdTRC.5. This cloning step
yielded the shuttle construct pAAV/AdTRC.7 (Fig. 1B).
The orientation of the neoR expression cassette in this
onstruct was such that the SpeI site adjacent to the lacZ
xpression cassette was preserved. Plasmid 221 was
enerated by subcloning into the ClaI site of pBlue-
1cript(SK ) (Stratagene), a 2.0-kb NarI fragment derived
rom GSE 1417 (Talbot et al., 1989) by partial digestion.
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244 GONC¸ALVES ET AL.The pAAV/AdTRC.14 shuttle construct (Fig. 1B) was ob-
tained by subcloning into the SpeI site of pAAV/AdTRC.7,
a 6.8-kb NheI fragment from intron 44 of the human
dystrophin gene (GenBank Accession No. M86524). The
construct pP5.REP contains the AAV rep open reading
frame (ORF) under control of its endogenous promoters,
whereas plasmid pCMV.E2a has the Ad5 E2a gene
driven by the IE-CMV promoter from pcDNA3 (Invitro-
gen).
Cells and virus vectors
Cells were cultured at 37°C in a humidified air–10%
CO2 atmosphere. For the production of virus vectors and
plaque assays we used PER.C6 cells (Fallaux et al.,
1998). These Ad5 E1-transformed human embryonic reti-
noblasts were maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM; Gibco BRL) containing 10% fetal
bovine serum (FBS) and 10 mM MgCl2. Transduction
xperiments were performed in tumor cell lines of human
HeLa, HepG2; American Type Culture Collection) and rat
L42 (Kal et al., 1986)] origin. These cells were main-
ained in DMEM supplemented with 10% FBS.
As helper virus for the production of AAV/Ad hybrid
ector preparations we used Ad.DE1.MLP.luc. In this
d5-based vector the viral E1 region is replaced by a
irefly luciferase gene driven by the Ad5 major late pro-
oter. To compare the performance of the AAV/Ad hybrid
ector with that of a recombinant Ad in long-term trans-
uction assays, Ad.DE1.CMV.lacZ was constructed.
d.DE1.CMV.lacZ is an E1-deleted Ad vector that con-
ains the same reporter gene cassette as the AAV/Ad
ybrid vector. The production, purification, and titration of
1-deleted Ad vector stocks has been previously de-
cribed in detail (Fallaux et al., 1998).
eneration of AAV/Ad hybrid vectors
PER.C6 cells were seeded in 100-mm culture dishes
Greiner) and were incubated overnight in a 10% CO2
atmosphere at 37°C. The next day, semiconfluent mono-
layers were transfected with either 12 mg of pP5.REP and
mg of one of the AAV ITR-containing shuttle constructs
or with 9 mg of pP5.REP, 5 mg of pCMV.E2a, and 3 mg of
either pAAV/AdTRC.5, pAAV/AdTRC.7, or pAAV/
AdTRC.14. The absence of pP5.REP or pCMV.E2a in
control samples was compensated by the addition of
equal amounts of pUC19 carrier DNA (Gibco BRL). Be-
fore addition to the cells, the DNA constructs were di-
luted in 100 ml of lipofectamine (Gibco BRL) plus 200 ml
f DMEM. To allow the formation of DNA–liposome com-
lexes, the mixtures were incubated for 30 min at room
emperature. Meanwhile, the cells were washed with 5
l of DMEM. Subsequently the DNA–liposome com-
lexes were diluted in DMEM to a final volume of 5 ml
nd the samples were added to the washed cells. After
n incubation period of 3 to 4 h at 37°C in a 10% CO2
t
5atmosphere, 5 ml of DMEM supplemented with 20% FBS
and 20 mM MgCl2 was added to the culture dishes. To
nfect the cells with Ad.DE1.MLP.luc helper vector, a
ultiplicity of infection (m.o.i.) of 5 infectious units (IU)
er cell was used. Following overnight incubation, the
ransfection medium was aspirated and fresh DMEM
upplemented with 10% FBS and 10 mM MgCl2 was
added. At 3 to 4 days posttransfection the cells were
harvested and lysed by three cycles of freezing and
thawing. The cellular debris was pelleted by centrifuga-
tion at 208 g for 10 min and the recovered supernatants
were clarified by filtration through 0.45-mm filters (Milli-
pore). The number of LFU in the supernatants was de-
termined histochemically as described below (b-galac-
osidase assay).
xtrachromosomal DNA extraction
Cells were collected by centrifugation at 48 h after
ransfection and washed with phosphate-buffered saline
PBS), pH 7.4. The cells were spun down again and
esuspended in 500 ml of proteinase K digestion buffer
10 mM Tris–HCl, pH 7.5; 10 mM EDTA containing 100
mg/ml proteinase K) per 107 cells. Next, an equal volume
of lysis buffer (10 mM Tris–HCl, pH 7.5; 10 mM EDTA; 1.2%
SDS) was added to the cell suspension and the mixture
was incubated for 30 min at 37°C. The sample was then
supplemented with NaCl to a final concentration of 1 M
and incubated for 3 h at 4°C. The chromosomal DNA–
protein complexes were precipitated by centrifugation
for 30 min at 20,800 g at 4°C and the recovered super-
atant was extracted twice with phenol–chloroform (1:1)
nd once with chloroform. The episomal DNA was pre-
ipitated from the aqueous phase with ethanol and dis-
olved in 10 mM Tris–HCl, pH 7.5, 1 mM EDTA containing
0 mg/ml DNase-free RNase A (Boehringer Mannheim).
o selectively degrade the prokaryotic DNA the samples
ere treated for 1 h at 37°C with the restriction endonu-
lease DpnI. After agarose gel electrophoresis the DNA
as transferred by capillarity to a nylon membrane (Hy-
ond N1; Amersham Pharmacia Biotech) and incubated
with a 32P-labeled EcoRI fragment corresponding to nu-
cleotides 22–3103 of the lacZ ORF. This probe was la-
beled using the RTS RadPrime DNA Labeling System
(Gibco BRL).
Propagation of AAV/Ad hybrid vectors
PER.C6 cells were seeded in 100-mm culture dishes.
After an overnight incubation period in a 10% CO2 atmo-
phere at 37°C, the semiconfluent monolayers were
ransfected either with 7.5 mg of pP5.REP and 7.5 mg of
CMV.E2a or with 7.5 mg of pUC19 and 7.5 mg of
CMV.E2a. For a detailed description of the transfection
rotocol see above (Generation of AAV/Ad hybrid vec-ors). At 24 h posttransfection the cells were infected with
0, 250, or 1250 ml of an AAV/AdTRC.14 hybrid vector
ao
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nd 3.2 3 109 IU/ml of Ad.DE1.MLP.luc helper virus. The
cells were harvested and lysed at 3 to 4 days posttrans-
fection by three cycles of freezing and thawing. The
cellular debris was pelleted by centrifugation at 208 g for
10 min and the recovered supernatants were clarified by
filtration through 0.45-mm filters (Millipore). The number
f LFU in the supernatants was determined histochemi-
ally as described below (b-Galactosidase assay).
b-Galactosidase assay
The lacZ transduction efficiencies were determined by
infecting confluent monolayers of HeLa or HepG2 cells
with serial fivefold dilutions of each vector preparation.
At 24 h postinfection the cells were washed with PBS
and fixed with 0.2% glutaraldehyde in PBS for 7 min at
room temperature. Next, the cells were rinsed with PBS
and incubated overnight at 37°C with 0.1 M sodium
phosphate, pH 7.2–7.4; 2 mM MgCl2; 5 mM K2Fe(CN)6;
and 5 mM K4Fe(CN)6 containing 1 mg/ml 5-bromo-4-
chloro-3-indolyl-b-galactopyranoside (X-Gal; Molecular
Probes). After an overnight incubation at 37°C the cell
layers were screened with an Olympus CK2-TR light
microscope for the presence of b-gal-positive (i.e., blue)
nuclei and the total number of LFU at a particular sample
dilution was used to calculate the gene transfer activity
of the undiluted vector preparation. The same staining
method was used to monitor lacZ expression at later
time points after infection.
Concentration of AAV/Ad hybrid vector particles by
CsCl gradient centrifugation
At 3 days posttransfection/infection AAV/Ad hybrid
vector producer cells were harvested and lysed by three
cycles of freezing and thawing. The cellular debris was
pelleted by low-speed centrifugation for 10 min and, to
the recovered supernatants, was added 0.5 vol of 20%
(w/v) polyethylene glycol 8000 (Sigma) dissolved in 2.5 M
NaCl. Vector particles were precipitated by incubation on
ice for at least 1 h. Approximately every 10 min the
solution was homogenized by gently inverting the tubes.
Next the precipitated particles were collected by centrif-
ugation at 9500 rpm for 30 min at 4° C in a C0650 rotor
(Beckman). The pellets were resuspended in 10 mM
sodium phosphate, pH 7.2–7.4 containing 7% glycerol.
This material was loaded onto a CsCl block gradient
comprising a layer of 1.4 g/ml and a layer of 1.24 g/ml.
After centrifugation at 21,000 rpm for 2 h at 10°C in a
SW28 rotor (Beckman), the vector was concentrated at
the 1.24–1.4 g/ml border and was retrieved by puncturing
the ultracentrifugation tube. The vector was extensively
dialyzed against PBS containing a final concentration of
5% (w/v) sucrose. The presence of AAV/Ad transducing
units in the dialyzed medium was confirmed by b-gal
histochemistry on Hela indicator cells. Prior to AAV/Adhybrid vector DNA purification by proteinase K digestion,
organic solvent extraction, and ethanol precipitation, a
DNase I treatment was performed to degrade any pos-
sible contaminating DNA. The particles were incubated
for 30 min at 37°C in a solution containing 13 mM
Tris–HCl, pH 7.5, 0.12 mM CaCl2, 5 mM MgCl2, and
DNase I at a final concentration of 0.3 mg/ml.
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